Several studies have documented that ex vivo neutrophils and monocytes from critically ill COVID-19 patients exhibited impaired cytokine release and consequently a decreased capacity to kill intracellular bacteria via production of reactive oxygen species (ROS) and intracellular myeloperoxidase (MPO) by neutrophils [116,204,205,206]. Here, MPO is linked to COVID-19.